Allarity Therapeutics, Inc.
ALLR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001860657
No open-market purchases or sales by Allarity Therapeutics, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Allarity Therapeutics, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 11 | 16 | +5 |
| Shares | 1.03M | 1.29M | +258.9K (+25.1%) |
| Value | $1.63M | $1.40M | −$237.1K (−14.5%) |
New holders (6)
Institutions that held Allarity Therapeutics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| DRW Securities, LLC | 122,741 | $132.6K | 0.01% |
| Capital Advisors Inc | 100,000 | $108.0K | 0.00% |
| XTX Topco Ltd | 33,644 | $36.3K | 0.00% |
| UBS Group AG | 26,516 | $28.6K | 0.00% |
| Two Sigma Securities, LLC | 13,594 | $14.7K | 0.00% |
| HRT Financial LP | 10,347 | $11.0K | 0.00% |
Sold out (1)
Institutions that held Allarity Therapeutics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Advisor Group Holdings, Inc. | 7 | $10 |